We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Pronota Awarded Euro 1.87M Grant by Flanders Government

Pronota Awarded Euro 1.87M Grant by Flanders Government

Pronota Awarded Euro 1.87M Grant by Flanders Government

Pronota Awarded Euro 1.87M Grant by Flanders Government

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Pronota Awarded Euro 1.87M Grant by Flanders Government"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Pronota NV has announced that it has been awarded a Euro 1.87M grant from the Flanders Government to further develop its diagnostic and pharmacodiagnostic protein biomarker discovery and validation platform.

The grant will be used to expand the development of Pronota’s first generation biomarker discovery platform by building on its capability to identify low abundant serum protein biomarkers.

In addition, Pronota plans to couple the discovery phase of the biomarker platform to a validation platform, making it possible to simultaneously assess the levels of a significant number of candidate biomarkers in large patient populations without the upfront requirement to generate antibodies and develop immunoassays. The remainder of the grant will be used to fund the execution of one of Pronota’s internal biomarker discovery programs.

Commenting on the grant, Dr Koen Kas, Founder and CSO of Pronota said: “The capability to discover and rapidly validate highly specific and sensitive biomarkers will bring Pronota to the forefront of the global biomarker effort, and will increase its marketing position tremendously. This award, coupled with the recent appointment of a new Chairman and a Business Development Director, shows Pronota’s commitment to becoming a leading predictive biomarker company.”

Pronota recently recruited John Berriman as Chairman and Huw Davies as Business Development Director.

The grant was awarded by the Flanders Government through IWT-Flanders, the Institute for the Promotion of Innovation by Science and Technology in Flanders.